[go: up one dir, main page]

GB201615550D0 - Detection and treatment of microsporidian infection - Google Patents

Detection and treatment of microsporidian infection

Info

Publication number
GB201615550D0
GB201615550D0 GBGB1615550.9A GB201615550A GB201615550D0 GB 201615550 D0 GB201615550 D0 GB 201615550D0 GB 201615550 A GB201615550 A GB 201615550A GB 201615550 D0 GB201615550 D0 GB 201615550D0
Authority
GB
United Kingdom
Prior art keywords
detection
treatment
microsporidian
infection
microsporidian infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1615550.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Benchmark Animal Health Ltd
Original Assignee
Benchmark Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benchmark Animal Health Ltd filed Critical Benchmark Animal Health Ltd
Priority to GBGB1615550.9A priority Critical patent/GB201615550D0/en
Publication of GB201615550D0 publication Critical patent/GB201615550D0/en
Priority to PCT/GB2017/052676 priority patent/WO2018051071A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961Plant cells or fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1615550.9A 2016-09-13 2016-09-13 Detection and treatment of microsporidian infection Ceased GB201615550D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1615550.9A GB201615550D0 (en) 2016-09-13 2016-09-13 Detection and treatment of microsporidian infection
PCT/GB2017/052676 WO2018051071A1 (en) 2016-09-13 2017-09-12 Detection and treatment of microsporidian infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1615550.9A GB201615550D0 (en) 2016-09-13 2016-09-13 Detection and treatment of microsporidian infection

Publications (1)

Publication Number Publication Date
GB201615550D0 true GB201615550D0 (en) 2016-10-26

Family

ID=57234525

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1615550.9A Ceased GB201615550D0 (en) 2016-09-13 2016-09-13 Detection and treatment of microsporidian infection

Country Status (2)

Country Link
GB (1) GB201615550D0 (en)
WO (1) WO2018051071A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111020050B (en) * 2020-01-13 2022-09-13 宁波大学 Primer and probe sequences for LAMP-LFD detection

Also Published As

Publication number Publication date
WO2018051071A9 (en) 2018-04-19
WO2018051071A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
HK1248711A1 (en) Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
HK1252873A1 (en) Vaccines for treatment and prevention of cancer
GB2554629B8 (en) Prevention and treatment of microbial infections
HK1243641A1 (en) Detection and treatment of excessive hair shedding
IL263368A (en) Prevention and treatment of viral infections
ZA201705634B (en) Quinoline derivatives for use in the treatment or prevention of viral infection
GB201413826D0 (en) Plasma treatment of an infected nail or infected skin
EP3600374C0 (en) Treatment of respiratory infection
IL264451B1 (en) Combination of abt-199 and imetelstat for treatment of aml
EP3186394A4 (en) Treatment and detection of melanoma
PL3183003T3 (en) Methods for prevention and/or treatment of infection
GB201413530D0 (en) Treatment and prevention of malaria
GB201616009D0 (en) Treatment and/or prevention of sepsis
ZA201708289B (en) Treatment and detection of trypanosomes
DK3229811T3 (en) PREVENTION AND TREATMENT OF INFLAMMATIONAL DISEASES
EP3687629A4 (en) Treatment and detection of infection and disease associated with different fungal pathogens
GB201409045D0 (en) Detection of bacterial infection
GB201615035D0 (en) Treatment and prevention of viral infection
GB201615550D0 (en) Detection and treatment of microsporidian infection
GB201518597D0 (en) Detection of bacterial infection
EP3146975A4 (en) Agent for prevention and treatment of chlamydia infection
GB201618432D0 (en) Detection and treatment of demyelinating diseases
GB201519483D0 (en) Prevention and treatment of microbial infections
GB201518252D0 (en) Prevention and treatment of microbial infections
GB201513047D0 (en) Prevention and treatment of microbial infections

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)